0000899243-22-003838.txt : 20220201
0000899243-22-003838.hdr.sgml : 20220201
20220201160531
ACCESSION NUMBER: 0000899243-22-003838
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211206
FILED AS OF DATE: 20220201
DATE AS OF CHANGE: 20220201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BELOFF GREGG
CENTRAL INDEX KEY: 0001171002
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37566
FILM NUMBER: 22578914
MAIL ADDRESS:
STREET 1: C/O CERULEAN PHARMA INC.
STREET 2: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNLOGIC, INC.
CENTRAL INDEX KEY: 0001527599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-401-9975
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Mirna Therapeutics, Inc.
DATE OF NAME CHANGE: 20110809
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-06
0
0001527599
SYNLOGIC, INC.
SYBX
0001171002
BELOFF GREGG
C/O SYNLOGIC, INC.
301 BINNEY STREET, SUITE 402
CAMBRIDGE
MA
02142
0
1
0
0
See Remarks
Stock Option (right to buy)
2.34
2021-12-06
4
A
0
50000
0.00
A
2031-12-06
Common Stock
50000
50000
D
The options were issued to the Reporting Person pursuant to the Issuer's 2015 Equity Incentive Award Plan. Such options vest in 12 equal monthly installments starting November 1, 2021, provided the Reporting Person continues to provide services to the Issuer. An aggregate of 50% of the options shall vest immediately if the Issuer terminates the Reporting Person's services before May 1, 2022.
Interim Chief Financial Officer
/s/ Gregg Beloff
2022-02-01